Catalyst Pharmaceuticals, Inc. (CPRX) Social Stream
Catalyst Pharmaceuticals Inc (CPRX) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Catalyst Pharmaceuticals Inc.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-05 | 5 | $11 | $6.5 | $8.5 | $8.33 | 2.04% |
| 2021-11-11 | 5 | $12 | $7 | $9.6 | $8.33 | 15.25% |
| 2022-01-13 | 5 | $12 | $7 | $9.8 | $8.33 | 17.65% |
| 2022-03-18 | 5 | $12 | $8 | $11 | $8.33 | 32.05% |
| 2022-03-27 | 5 | $12 | $8.75 | $10.95 | $8.33 | 31.45% |
The Trend in the Analyst Price Target
CPRX's average price target has moved up $2.65 over the prior 29 weeks.
Over the past 50 weeks, CPRX's average upside potential has been 46.6%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-04-17 | 0 | 9 | 5.5 | 7.5 | 4.44 | 68.92% |
| 2021-05-22 | 0 | 9 | 5.5 | 7.5 | 5.70 | 31.58% |
| 2021-08-07 | 0 | 11 | 5.5 | 8.1 | 5.81 | 39.41% |
| 2021-09-20 | 0 | 11 | 6.5 | 8.3 | 4.85 | 71.13% |
| 2022-01-13 | 5 | 12 | 7.0 | 9.8 | 6.14 | 59.61% |
CPRX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 5 | 0 | 0 | 0 | 0 | 5 |
The Trend in the Broker Recommendations
CPRX's average broker recommendation rating improved by 0 over the prior 59 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Catalyst Pharmaceuticals Inc fares relative to all US stocks, note that its average analyst price target is greater than 43.76% of that group.
- In terms of how Catalyst Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 53.2% of that group.
- To contextualize these metrics, consider that out of stocks in the small market cap category, Catalyst Pharmaceuticals Inc's number of analysts covering the stock is greater than 319.3% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Catalyst Pharmaceuticals Inc's variance in analysts' estimates is lower than -85.82% of them.
Stocks similar to Catalyst Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CPIX, COLL, and COGT.
Is CPRX a Buy, Hold or Sell? See the POWR Ratings now!